Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Visible Genomics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Visible Genomics

Visible Genomics

Seed

Visible Genomics: Clinically validated, state-of-the-art AMD risk assessment provider.

HQ
Oakbrook Terrace, IL, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Visible Genomics, founded with a mission to empower individuals with knowledge about their eye health, specializes in providing clinically validated, state-of-the-art risk assessments for age-related macular degeneration (AMD). The company offers genetic testing services that help predict the risk of developing AMD, enabling early intervention and personalized care. Their market focus includes individuals at risk of AMD, healthcare providers, and researchers in ophthalmology.

Notable affiliated people include a dedicated clinical advisory board comprising experts in genetics and ophthalmology. Visible Genomics has garnered attention for its innovative approach to AMD risk assessment, contributing significantly to preventive eye care. By offering accessible and reliable genetic testing, the company has made a substantial impact on improving patient outcomes and advancing the understanding of AMD.

Visible Genomics - Similar Companies

Nucleus logo

Nucleus

Allelica logo

Allelica

allelica.com

Color logo

Color

color.com

Pathway Genomics logo

Pathway Genomics

Visgenx logo

Visgenx

visgenx.com

Geneicd logo

Geneicd

Invitae logo

Invitae

invitae.com

23andMe logo

23andMe

23andme.com

Genomenon logo

Genomenon

genomenon.com

FamGenix logo

FamGenix

famgenix.com

Genome Insight logo

Genome Insight

Variantyx logo

Variantyx

variantyx.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

VitaPath Genetics logo

VitaPath Genetics

Genomic Prediction logo

Genomic Prediction

Visible Genomics - Quick Facts

Who are Visible Genomics' competitors?

Companies similar to Visible Genomics include Nucleus, Allelica, Color and Pathway Genomics.

When was Visible Genomics founded?

Visible Genomics was founded in 2019.

Where is Visible Genomics' headquarters located?

Visible Genomics' headquarters is located in Oakbrook Terrace, IL, US.

When was Visible Genomics' last funding round?

Visible Genomics' most recent funding round was for $190k (USD) in June 2019.

How much has Visible Genomics raised to-date?

As of Jun 3, 2019, Visible Genomics has raised a total of $190k (USD).

How many employees does Visible Genomics have?

Visible Genomics has 5 employees as of Feb 4, 2024.

Visible Genomics - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Genetic Testing
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software